GLIPR1L2

Across TCGA pan-cancer cohorts, GLIPR1L2 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated GLIPR1L2 data layer compared with 22 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher GLIPR1L2 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated GLIPR1L2 expression acts as an unfavorable survival marker.

CCRCC are the cancer types where GLIPR1L2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	All	0.472	1.000	.003	15	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

GLIPR1L2–CCRCC (OS)

Open the CCRCC breakdown →